SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹24 Cr | ₹31 Cr | ₹30 Cr | ₹4.59 Cr | ₹-5.22 Cr |
What is the latest Cash Flow from Operating Activities ratio of SHREE GANESH REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹24 Cr |
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2020 | ₹4.59 Cr |
| Mar2019 | ₹-5.22 Cr |
How is Cash Flow from Operating Activities of SHREE GANESH REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹24 Cr | -22.57 | |
| Mar2025 | ₹31 Cr | 0.71 | |
| Mar2024 | ₹30 Cr | 563.81 | |
| Mar2020 | ₹4.59 Cr | Positive | |
| Mar2019 | ₹-5.22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹789.8 Cr | -2.1% | -7.6% | 30.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -2.1% |
-7.6% |
30.1% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses